Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | Ilya Pharma Ab |
| Country | Sweden |
| Start Date | Jul 15, 2021 |
| End Date | Oct 20, 2021 |
| Duration | 97 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2021-02448_Vinnova |
Purpose and goal: ** Denna text är maskinöversatt ** Aim: The proposed project aims to improve the positioning for an international grant application with significant funds Objective: -Quantify medical needs, pipeline and market in two medical indications -Develop a synopsis first with experts for a trial
Expected results and effects: ** Denna text är maskinöversatt **
Medical need, pipeline and market have been defined in two medical indications for the company´s other drug candidate ILP100-Oral. One of the indications has been selected for the clinical development program and a synopsis for a first clinical trial has been prepared together with relevant medical experts.
The data has been used in project proposals for two international calls with significant scope. Approach and implementation: ** Denna text är maskinöversatt **
The work has been carried out with internal and external resources, all work packages have been carried out according to plan.
Ilya Pharma Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant